Drew Dennison is the Chief Executive Officer of Microbial Machines. Drew is also the Managing Director of Lightchain Capital, LLC, the family office for Scottrade Founder and former Chief Executive Officer Rodger Riney. At Lightchain, Drew is responsible for venture capital investments in early-stage life science companies. Previously, Drew served as the Chief Operating Officer and Chief Financial Officer at Scottrade Financial Services, where he led the Company’s operations, technology, operations, finance, and strategic planning functions. Drew managed the sale of Scottrade to TD Ameritrade and co-led the integration project that successfully combined the two companies. In addition, Drew serves as chairman of the board of Geneoscopy, and serves on the boards of NextRNA, Mana Therapeutics, Wugen, Arch Onocology, Raqia Therapeutics, and SimpleRose.
He received a BBA in Accounting from University of Iowa – Henry B. Tippie College of Business where he graduated Cum Laude and is a graduate of the Wharton School’s Securities Industries Institute Executive Education Program.